OVID - Ovid Therapeutics GAAP EPS of -$0.23 misses by $0.02 revenue of $1.45M May, 10 2022 08:46 AM Ovid Therapeutics Inc. Ovid Therapeutics press release (NASDAQ:OVID): Q1 GAAP EPS of -$0.23 misses by $0.02. Revenue of $1.45M (-99.3% Y/Y). For further details see: Ovid Therapeutics GAAP EPS of -$0.23 misses by $0.02, revenue of $1.45M